IndraLab

Statements

Hydroxychloroquine activates Phase I Trial. 1 / 1

| 1

reach

"Current clinical trials are testing whether chloroquine and its derivative, hydroxychloroquine, could enhance chemotherapeutic efficacy (e.g. in the Phase I Trial of MK-2206 and Hydroxychloroquine in Solid Tumors, Melanoma, Renal, and Prostate Cancer [ClinicalTrials.gov Identifier, NCT01480154])."

26365175

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Hydroxychloroquine activates Phase I Trial. 1 / 1

INDRA sources:

Databases

Reading